Search

everythinglearnresearchcommunity

for

Search:↓

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

Using steroids can increase the risk of heart problems.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Topical latanoprost doesn't effectively regrow hair in severe eyebrow alopecia areata cases.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Topical minoxidil effectively and safely treats extensive alopecia areata but doesn't change its course.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Skin pigmentation varies due to genetics, UV exposure, and medications, with treatments available but requiring medical advice.

Some people with heavy hair shedding might actually have a hidden form of alopecia, which can be identified by specific hair changes.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Gene therapy, especially using atoh1, shows promise for creating functional sensory hair cells in the inner ear, but dosing and side effects need to be managed for clinical application.

Immune cells affect hair growth and could lead to new hair loss treatments.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

People with alopecia areata have a higher risk of stroke.

Korean Red Ginseng may help improve hair regrowth when used with corticosteroid injections for Alopecia Areata.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.